Paper36906936
Pharmacokinetic and pharmacodynamic considerations for treating sarcoptic mange with cross-relevance to Australian wildlife.
Takano K and 4 others. Int J Parasitol Drugs Drug Resist, 2023. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Pharmacokinetic and pharmacodynamic considerations for treating sarcoptic mange with cross-relevance to Australian wildlife. Papers, record 36906936. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36906936
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacokinetic and pharmacodynamic considerations for treating sarcoptic mange with cross-relevance to Australian wildlife.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Scabies | Major topic |
| Acaricides | Major topic |
| Animals | |
| Humans | |
| Animals, Wild | |
| Australia | |
| Sarcoptes scabiei | |
| Mammals |
Source PubMed
References240
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33720993 | Two novel loci underlie natural differences in Caenorhabditis elegans abamectin responses. | PLoS Pathog | 2021 | https://conductscience.org/library/papers/33720993 | PubMed |
| 2 | 27012161 | Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis. | Parasite | 2016 | https://conductscience.org/library/papers/27012161 | PubMed |
| 3 | 15463742 | Ivermectin resistance. | Parasitol Today | 1993 | https://conductscience.org/library/papers/15463742 | PubMed |
| 4 | 34309214 | Frequencies and mechanisms of pesticide resistance in Tetranychus urticae field populations in China. | Insect Sci | 2022 | https://conductscience.org/library/papers/34309214 | PubMed |
| 5 | 30025642 | The role of glutathione S-transferases (GSTs) in insecticide resistance in crop pests and disease vectors. | Curr Opin Insect Sci | 2018 | https://conductscience.org/library/papers/30025642 | PubMed |
| 6 | 17851096 | The pharmacokinetics and metabolism of ivermectin in domestic animal species. | Vet J | 2009 | https://conductscience.org/library/papers/17851096 | PubMed |
| 7 | 35155125 | Intravenous veterinary ivermectin in a COVID-19 patient causing neurotoxicity. | IDCases | 2022 | https://conductscience.org/library/papers/35155125 | PubMed |
| 8 | 10716995 | The genetics of ivermectin resistance in Caenorhabditis elegans. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10716995 | PubMed |
| 9 | 17004957 | Clinical presentation and management of moxidectin toxicity in two dogs. | J Small Anim Pract | 2006 | https://conductscience.org/library/papers/17004957 | PubMed |
| 10 | 33407820 | Fluralaner as a novel treatment for sarcoptic mange in the bare-nosed wombat (Vombatus ursinus): safety, pharmacokinetics, efficacy and practicable use. | Parasit Vectors | 2021 | https://conductscience.org/library/papers/33407820 | PubMed |
| 11 | 7082235 | The use of amitraz in the control of an outbreak of sarcoptic mange in a colony of koalas. | Aust Vet J | 1982 | https://conductscience.org/library/papers/7082235 | PubMed |
| 12 | 29089046 | The novel isoxazoline ectoparasiticide lotilaner (Credelio™): a non-competitive antagonist specific to invertebrates γ-aminobutyric acid-gated chloride channels (GABACls). | Parasit Vectors | 2017 | https://conductscience.org/library/papers/29089046 | PubMed |
| 13 | 14635176 | Chloride channels as tools for developing selective insecticides. | Arch Insect Biochem Physiol | 2003 | https://conductscience.org/library/papers/14635176 | PubMed |
| 14 | 18335094 | Outcomes of the California ban on pharmaceutical lindane: clinical and ecologic impacts. | Environ Health Perspect | 2008 | https://conductscience.org/library/papers/18335094 | PubMed |
| 15 | 27732588 | Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model. | PLoS Negl Trop Dis | 2016 | https://conductscience.org/library/papers/27732588 | PubMed |
| 16 | 12359484 | Breed differences on the plasma availability of moxidectin administered pour-on to calves. | Vet J | 2002 | https://conductscience.org/library/papers/12359484 | PubMed |
| 17 | 11714703 | Identification of two novel Drosophila melanogaster histamine-gated chloride channel subunits expressed in the eye. | J Biol Chem | 2002 | https://conductscience.org/library/papers/11714703 | PubMed |
| 18 | 9154544 | Success of a scabies control program in an Australian aboriginal community. | Pediatr Infect Dis J | 1997 | https://conductscience.org/library/papers/9154544 | PubMed |
| 19 | 15135868 | Dermal safety study with imidacloprid/moxidectin topical solution in the ivermectin-sensitive collie. | Vet Parasitol | 2004 | https://conductscience.org/library/papers/15135868 | PubMed |
| 20 | 15206075 | First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. | Clin Infect Dis | 2004 | https://conductscience.org/library/papers/15206075 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42093003 | Selection of the optimal long-acting injectable formulation of ivermectin for use in humans to target malaria vectors in Western Africa: evaluation of pharmacokinetics and mosquitocidal efficacy in cattle under laboratory conditions. | Parasit Vectors | 2026 | https://conductscience.org/library/papers/42093003 | PubMed |
| 40225591 | Pharmacokinetics and safety of topical fluralaner in koalas (Phascolarctos cinereus ). | Int J Parasitol Parasites Wildl | 2024 | https://conductscience.org/library/papers/40225591 | PubMed |
| 39109221 | Ivermectin therapy for young children with scabies infection: a multicentre phase 2 non-randomized trial. | Lancet Reg Health West Pac | 2024 | https://conductscience.org/library/papers/39109221 | PubMed |
| 39010037 | Global prevalence and predictors of scabies among prisoners: systematic review and meta-analysis. | BMC Public Health | 2024 | https://conductscience.org/library/papers/39010037 | PubMed |
| 38664829 | Assessment of the in vitro acaricidal activity of Bravecto® (fluralaner) and a proposed orange oil-based formulation vehicle for the treatment of Sarcoptes scabiei. | Parasit Vectors | 2024 | https://conductscience.org/library/papers/38664829 | PubMed |
| 38433167 | Scabies: Immunopathogenesis and pathological changes. | Parasitol Res | 2024 | https://conductscience.org/library/papers/38433167 | PubMed |
| 37656230 | Evaluation of the scabicidal effect of a single dose of fluralaner in a rabbit model of crusted scabies. | Parasitol Res | 2023 | https://conductscience.org/library/papers/37656230 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| PGP | 283871 | PubTator's text mining | https://conductscience.org/library/genes/283871 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36906936
GET https://conductscience.org/api/papers/v1/36906936/references?page=2